Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Resveratrol Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

NCT02030977 is registered in ClinicalTrials.gov with Dr Azita Hekmatdoost as lead sponsor.

NCT NCT02030977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02030977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Resveratrol Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
Lead sponsor
Dr Azita Hekmatdoost
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2012
Completion date
March 31, 2013
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver